IVERTERO (Ivermectin) is a broad spectrum anti-parasitic agent, included in WHO essential medicines list for several parasitic diseases. It is used in the treatment of onchocerciasis (river blindness), strongyloidiasis and other diseases caused by soil transmitted helminthiasis. It is also used to treat scabies.
In recent years, IVERTERO (Ivermectin) has shown to have anti-viral activity against a broad range of viruses. IVERTERO (Ivermectin) acts by inhibiting the host importin alpha/beta-1 nuclear transport proteins, which are part of a key intracellular transport process that viruses hijack to enhance infection by suppressing the host’s antiviral response.
IVERTERO (Ivermectin) have also reported potential anti-inflammatory properties, which have been postulated to be beneficial in people with COVID-19
For Covid, IVERTERO (Ivermectin) is one of the latest silver bullets and an inexpensive anti-parasitic. IVERTERO (Ivermectin) has antiviral action against the SARS-CoV-2. IVERTERO (Ivermectin) if given to patients early in infection, could help to